CorMedix (CRMD)

• Market cap: $854M
• 1 day: -2.33%
• 5 days: -7.78%
• 1 month: -5.71%
• 3 months: -8.79%
• 6 months: -2.33%
• Year to date: 32.6%
• 1 year: 5.62%
• 5 years: 108.41%
• 10 years: -21.3%
• Sector: Healthcare
• Industry: Biotechnology

About: Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

Employees: 82